medZERO launches no-cost GLP-1 benefit for employers

medZERO has introduced medACCESS, a turnkey benefit that gives employees access to patient-specific compounded GLP-1 medications at no cost to employers. Savage Industries, Easterseals of Louisiana and Salt & Straw are among the first employers to offer the new benefit as GLP-1 coverage costs keep climbing.

Why it matters: - Employers are under pressure from rising demand for GLP-1 medications and higher prescription costs. - medACCESS is designed to give employees access to these drugs without adding employer premiums, cost-sharing or stop-loss exposure. - The launch comes as some major employers and insurers pull back GLP-1 coverage for weight loss because of cost. - Obesity also carries a broader financial burden, including estimated annual U.S. medical costs of nearly $173 billion and productivity losses of $13 billion to $27 billion.

What happened: - medZERO launched medACCESS, a no-cost employer benefit for patient-specific compounded GLP-1 medications. - The benefit was announced August 25, 2026, in Portland, Oregon. - Savage Industries, Easterseals of Louisiana and Salt & Straw are among the first employers to add medACCESS to their medZERO benefits offering. - medACCESS is available as part of the medZERO offering or as a standalone benefit.

The details: - medACCESS requires only that an employer opt in to offer the benefit. - medZERO handles enrollment, prescribing access, clinical support and repayment. - Employees are connected with licensed U.S. physicians who evaluate, prescribe and oversee care. - Medications are fulfilled by FDA-regulated, LegitScript-certified pharmacies and shipped directly to employees' homes. - Employers pay no premium, no PEPM, no cost-share and no stop-loss exposure. - Employers receive deidentified utilization reporting on engagement and usage trends. - Employees get one monthly price that includes medication, clinical care, supplies and home delivery. - The price does not change with dose increases. - Employees can buy 3-, 6- or 12-month bundles for $500 to $700 in annual savings. - Employees with a medZERO account can use interest-free medZERO funds to help cover the cost. - Standard payment options remain available. - medZERO says the benefit can be offered with any health plan, any provider and any HSA.

Between the lines: - medACCESS is aimed at employers trying to balance employee demand for GLP-1 access with rapid benefit-cost inflation. - medZERO is positioning the product as a simpler alternative to consumer-direct GLP-1 offerings, which often start with lower advertised prices but add membership fees or higher dose costs later. - Craig Froude, medZERO's CEO, said the product reflects employee demand and the company's mission to make care more affordable and accessible. - Laurel Timmins, VP of Talent Acquisition & Total Rewards at Savage, said the company sees benefits as a strategic investment in workers and talent retention.

What's next: - Employers, associations, health plans and other partners can add medACCESS to their benefit portfolios. - medZERO is marketing the product to organizations that want GLP-1 access without new employer-side costs. - The company is also likely to use utilization data from the benefit to support future product adoption and expansion.

The bottom line: - medZERO is betting employers will pay for a simpler path to GLP-1 access only if the cost stays entirely on the employee side and administration stays light.